Olympiad Research’s Agilon Health AGL Stock Holding History

Olympiad Research’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-529	Closed	-$235K	–	315
2023 Q3	$235K	Buy	+529	New	+$239K	0.23%	208

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Olympiad Research's AGL Position: Q4 2023 in Review

Olympiad Research sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 529 shares — an estimated $235K sold.

Olympiad Research first reported a position in AGL in Q3 2023 and held it in 1 quarter. The position peaked at $235K in Q3 2023. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

Olympiad Research reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
Olympiad Research sold 529 Agilon Health shares in Q4 2023, an estimated $235K.
Olympiad Research first reported a position in Agilon Health in Q3 2023 and held it in 1 quarter.
Olympiad Research's Agilon Health position peaked at $235K in Q3 2023.
193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Olympiad Research's 13F filing for Q4 2023, filed 12 Feb 2024.